Can image-guided external beam radiotherapy boost be an alternative when intracavitary brachytherapy is unavailable for locally advanced cervical cancer? A dosimetric analysis and literature review [0.03%]
当腔内近距离放疗不可用时，图像引导的外照射能否成为局部晚期宫颈癌治疗的替代选择？剂量分析与文献回顾
Chaoxing Liu,Xiaoyan Wang,Na Zhang et al.
Chaoxing Liu et al.
Purpose: Intracavitary brachytherapy (ICBT) is a critical component of definitive radiotherapy for locally advanced cervical cancer (LACC). However, ICBT may be unavailable due to resource limitations, anatomical constrai...
Automated planning in image-guided adaptive brachytherapy for cervical cancer: Impact analysis on patient workflows in high-volume centers [0.03%]
图像引导自适应后装治疗宫颈癌的自动化计划对高容量中心患者流程影响分析
Varsha Hande,Linda Rossi,Henrike Westerveld et al.
Varsha Hande et al.
Purpose: Image-guided adaptive brachytherapy (IGABT) improves outcomes in locally advanced cervical cancer, but remains resource- and time-intensive, particularly during treatment planning. This study evaluated the impact...
Volume not the defining metric: Dosimetric benefits of adding supplemental interstitial needles for small volume cervical tumors [0.03%]
体积不是决定性指标：为小体积宫颈肿瘤添加补充间质针的剂量学优势
Emily Smith,Nicholas Ngo,Thomas Niedermayr et al.
Emily Smith et al.
Purpose: In brachytherapy for cervical cancer, previous data have demonstrated improved local control with adding supplementary interstitial needles for cervical tumors > 30 cm3 and increased D90 to high-risk clinical tar...
Iridium-192 high-dose-rate calibration discrepancies: A growing concern? [0.03%]
铱-192高剂量率校准差异：一个日益增长的担忧吗？
Paul Simpson,Emily Debrot,Neisha Hartfield et al.
Paul Simpson et al.
Purpose: An increasing discrepancy between the measured reference air kerma rate (RAKR) of high-dose-rate (HDR) iridium-192 (192Ir) sources and that reported by the manufacturer on the source certificate was observed at a...
Development of a patient-specific adaptive ring for organ at risk contours in high-dose-rate brachytherapy gynecologic cancers [0.03%]
适形高剂量率后装放疗妇科肿瘤时保护危及器官的个体化自适应环装置的研发
Sruthi Sivabhaskar,Yesenia Gonzalez,Paul Medin et al.
Sruthi Sivabhaskar et al.
Purpose: High-dose-rate (HDR) brachytherapy for gynecologic cancers requires repeated organ at risk (OAR) contouring for each fraction, which is a time-consuming task susceptible to variability. This study evaluated the u...
Ruthenium-106 ocular surface brachytherapy for incompletely excised conjunctival melanoma and squamous cell carcinoma [0.03%]
用于未能完全切除的睑结膜黑色素瘤和鳞状细胞癌的眼表近距离放射治疗
Efstathios T Detorakis,Georgia Solomou,Maria Detoraki et al.
Efstathios T Detorakis et al.
Purpose: To examine the efficacy and safety of ruthenium-106 (106Ru) ocular surface brachytherapy for incompletely excised conjunctival melanoma (CM) and conjunctival squamous cell carcinoma (CSCC) patients, with no adjun...
Efficacy of peri-operative high-dose-rate interstitial brachytherapy in keloids: Can we scare the bad scar? [0.03%]
术前术后应用高剂量率组织间放射治疗瘢痕疙瘩的疗效：能否根治瘢痕？
Kilaru Sneha,Ayesha Iqbal Maniyar,Lithika Lavanya et al.
Kilaru Sneha et al.
Purpose: Keloids arise from dysregulated wound healing, characterized by excessive fibroblast activity and collagen deposition. Despite multiple treatment modalities, recurrence rates after excision remain high. High-dose...
Automated EQD2 reporting for cervical cancer high-dose-rate brachytherapy using a standalone ESAPI-based application [0.03%]
基于ESAPI的独立应用程序在宫颈癌高剂量率后装治疗中自动报告EQD2值
Bojan Pavičar,Dejan Kukić,Andrej Milosavljević et al.
Bojan Pavičar et al.
Purpose: Reporting cumulative equivalent dose in 2 Gy fractions (EQD2) for combined external beam radiotherapy (EBRT) and gynecologic high-dose-rate brachytherapy (HDR-BT) typically requires manual transcription of dose-v...
Outcomes of cervical carcinoma patients treated with chemoradiation and single-application two-fractions schedule of high-dose-rate brachytherapy: A retrospective review (SATF study) [0.03%]
单剂量分割高剂量率后装放疗联合内外照射治疗宫颈癌患者回顾性分析（单分次双份次高剂量率后装放疗研究）
Abhishek Shinghal,Abhishek Chakravarty,Tanvee Singla et al.
Abhishek Shinghal et al.
Purpose: Brachytherapy remains integral component in curative-intent management of locally advanced cervical cancer, with overall treatment time (OTT) strongly influencing outcomes. In this study, we intended to analyze s...
The value of pre-brachytherapy MRI in aiding applicator selection for cervical cancer procedures [0.03%]
术前MRI辅助选择宫颈癌操作器具的价值
Jennifer S Chiang,Abass M Conteh,Thomas Niedermayr et al.
Jennifer S Chiang et al.
Purpose: Brachytherapy applicator selection in the treatment of cervical cancer often relies on intra-operative judgment. Pre-brachytherapy magnetic resonance imaging (pre-MRI) may provide earlier guidance for most approp...